DeepMatter (LON: DMTR) shares have gained on Thursday after announcing it has begun a project with the University of Cambridge's Innovation Centre in Digital Molecular Technologies (iDMT).
The centre is an open innovation research centre co-funded by the University of Cambridge, AstraZeneca, Shionogi, and the European Regional Development Fund.
DeepMatter said it will provide its DigitalGlassware platform to iDMT as part of developing a fully digital workflow in the discovery and development of new molecules, materials, reactions, and processes.
Mark Warne, CEO of DeepMatter Group, commented: “This is another important step in rolling out our flagship platform DigitalGlassware, with the key opinion leaders in the academic world allowing us to demonstrate publicly its ability to discover new molecules and routes to molecules in a way that would not otherwise be able. The expertise we can garner by engaging with these influential institutions will be invaluable in helping us to innovate our platform even further.
“We are now establishing DigitalGlassware as the go-to platform for capturing and structuring time-course sensor data in the lab, to enable improved insights for better productivity and discovery.”
DeepMatter's share price is up 1.23% at 1.645p following the news.
Should you invest in DeepMatter shares?
DeepMatter shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are DeepMatter shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies